Liver Diseases  >>  nivocasan (GS-9450)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
nivocasan (GS-9450) / Gilead
NCT00740610 / 2008-002361-31: Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)

Completed
2
124
US, Europe
GS-9450, GS-9450 Placebo
Gilead Sciences
Nonalcoholic Steatohepatitis
08/09
09/09

Download Options